Works by Agbarya, Abed


Results: 43
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13

    Treatment of Rare Mutations in Patients with Lung Cancer.

    Published in:
    Biomedicines, 2021, v. 9, n. 5, p. 534, doi. 10.3390/biomedicines9050534
    By:
    • Taha, Tarek;
    • Khoury, Rasha;
    • Brenner, Ronen;
    • Nasrallah, Haitam;
    • Shofaniyeh, Irena;
    • Yousef, Samih;
    • Agbarya, Abed;
    • Ricci, Alberto;
    • Mancini, Rita
    Publication type:
    Article
    14
    15

    Oncology Treatments during the COVID-19 Pandemic in Israel: the ONCOR Study.

    Published in:
    Israel Medical Association Journal, 2021, v. 23, n. 12, p. 759
    By:
    • Hirsh-Yechezkel, Galit;
    • Chetrit, Angela;
    • Avraham, Sivan Ben;
    • Agbarya, Abed;
    • Yakobson, Alexander;
    • Asna, Noam;
    • Bar-Sela, Gil;
    • Ben-Aharon, Irit;
    • Ben-Baruch, Noa Efrat;
    • Berger, Raanan;
    • Brenner, Ronen;
    • Gottfried, Maya;
    • Paluch-Shimon, Shani;
    • Pfeffer, Raphael;
    • Popovtzer, Aron;
    • Ryvo, Larisa;
    • Semenisty, Valeriya;
    • Shai, Ayelet;
    • Shulman, Katerina;
    • Zidan, Jamal
    Publication type:
    Article
    16

    Molecular Profiling-Selected Therapy for Treatment of Advanced Pancreaticobiliary Cancer: A Retrospective Multicenter Study.

    Published in:
    BioMed Research International, 2015, v. 2015, p. 1, doi. 10.1155/2015/681653
    By:
    • Epelbaum, Ron;
    • Shacham-Shmueli, Einat;
    • Klein, Baruch;
    • Agbarya, Abed;
    • Brenner, Baruch;
    • Brenner, Ronen;
    • Gez, Eliahu;
    • Golan, Talia;
    • Hubert, Ayala;
    • Purim, Ofer;
    • Temper, Mark;
    • Tepper, Ella;
    • Voss, Andreas;
    • Russell, Kenneth;
    • Dvir, Addie;
    • Soussan-Gutman, Lior;
    • Stemmer, Salomon M.;
    • Geva, Ravit
    Publication type:
    Article
    17
    18
    19
    20
    21

    Efficacy and Safety of BRAF Inhibitors With or Without MEK Inhibitors in BRAF-Mutant Advanced Non-Small-Cell Lung Cancer: Findings From a Real-Life Cohort.

    Published in:
    2019
    By:
    • Dudnik, Elizabeth;
    • Bar, Jair;
    • Peled, Nir;
    • Bshara, Elias;
    • Kuznetsov, Teodor;
    • Cohen, Aharon Yonathan;
    • Shochat, Tzippy;
    • Nechushtan, Hovav;
    • Onn, Amir;
    • Agbarya, Abed;
    • Moskovitz, Mor;
    • Keren, Shoshana;
    • Popovits-Hadar, Noa;
    • Urban, Damien;
    • Mishaeli, Moshe;
    • Rabinovich, Natalie Maimon;
    • Brenner, Ronen;
    • Zer, Alona;
    • Rotem, Ofer;
    • Roisman, Laila C.
    Publication type:
    journal article
    22
    23
    24
    25
    26
    27
    28

    Crizotinib acts as ABL1 inhibitor combining ATP-binding with allosteric inhibition and is active against native BCR-ABL1 and its resistance and compound mutants BCR-ABL1T315I and BCR-ABL1T315I-E255K.

    Published in:
    Annals of Hematology, 2021, v. 100, n. 8, p. 2023, doi. 10.1007/s00277-020-04357-z
    By:
    • Mian, Afsar Ali;
    • Haberbosch, Isabella;
    • Khamaisie, Hazem;
    • Agbarya, Abed;
    • Pietsch, Larissa;
    • Eshel, Elizabeh;
    • Najib, Dally;
    • Chiriches, Claudia;
    • Ottmann, Oliver Gerhard;
    • Hantschel, Oliver;
    • Biondi, Ricardo M.;
    • Ruthardt, Martin;
    • Mahajna, Jamal
    Publication type:
    Article
    29
    30
    31

    Real-World Data on Osimertinib-Associated Cardiac Toxicity.

    Published in:
    Journal of Clinical Medicine, 2025, v. 14, n. 5, p. 1754, doi. 10.3390/jcm14051754
    By:
    • Agbarya, Abed;
    • Raphael, Ari;
    • Gantz Sorotsky, Hadas;
    • Rottenberg, Yakir;
    • Šebek, Viktor;
    • Radonjic, Dejan;
    • Yakobson, Alexander;
    • Arnon, Johnathan;
    • Shalata, Walid
    Publication type:
    Article
    32
    33

    Unexpected and Rare Sites of Metastasis in Oncologic Patients.

    Published in:
    Journal of Clinical Medicine, 2023, v. 12, n. 20, p. 6447, doi. 10.3390/jcm12206447
    By:
    • Shalata, Walid;
    • Abu Jama, Ashraf;
    • Abu Salman, Amjad;
    • Golosky, Mitchell;
    • Solomon, Adam;
    • Abu Saleh, Omar;
    • Michlin, Regina;
    • Shalata, Sondos;
    • Agbarya, Abed;
    • Yakobson, Alexander
    Publication type:
    Article
    34

    FGFR Fusions as an Acquired Resistance Mechanism Following Treatment with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors (EGFR TKIs) and a Suggested Novel Target in Advanced Non-Small Cell Lung Cancer (aNSCLC).

    Published in:
    Journal of Clinical Medicine, 2022, v. 11, n. 9, p. 2475, doi. 10.3390/jcm11092475
    By:
    • Raphael, Ari;
    • Dudnik, Elizabeth;
    • Hershkovitz, Dov;
    • Jain, Suyog;
    • Olsen, Steve;
    • Soussan-Gutman, Lior;
    • Ben-Shitrit, Taly;
    • Dvir, Addie;
    • Nechushtan, Hovav;
    • Peled, Nir;
    • Onn, Amir;
    • Agbarya, Abed
    Publication type:
    Article
    35
    36
    37

    Biological insights from plasma proteomics of non-small cell lung cancer patients treated with immunotherapy.

    Published in:
    Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1364473
    By:
    • Bar, Jair;
    • Leibowitz, Raya;
    • Reinmuth, Niels;
    • Ammendola, Astrid;
    • Jacob, Eyal;
    • Moskovitz, Mor;
    • Levy-Barda, Adva;
    • Lotem, Michal;
    • Katsenelson, Rivka;
    • Agbarya, Abed;
    • Abu-Amna, Mahmoud;
    • Gottfried, Maya;
    • Harkovsky, Tatiana;
    • Wolf, Ido;
    • Tepper, Ella;
    • Loewenthal, Gil;
    • Yellin, Ben;
    • Brody, Yehuda;
    • Dahan, Nili;
    • Yanko, Maya
    Publication type:
    Article
    38

    Lower lung cancer rates in Jewish smokers in Israel and the USA.

    Published in:
    International Journal of Cancer, 2015, v. 137, n. 9, p. 2155, doi. 10.1002/ijc.29587
    By:
    • Rennert, Gad;
    • Kremer, Ran;
    • Rennert, Hedy S.;
    • Wollner, Mira;
    • Agbarya, Abed;
    • Pinchev, Mila;
    • Lejbkowicz, Flavio;
    • Spitz, Margaret R.;
    • Muscat, Joshua E.
    Publication type:
    Article
    39
    40
    41

    The Impact of Comprehensive Genomic Profiling (CGP) on the Decision-Making Process in the Treatment of ALK-Rearranged Advanced Non-Small Cell Lung Cancer (aNSCLC) After Failure of 2<sup>nd</sup>/3<sup>rd</sup>-Generation ALK Tyrosine Kinase Inhibitors (TKIs)

    Published in:
    Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.874712
    By:
    • Raphael, Ari;
    • Onn, Amir;
    • Holtzman, Liran;
    • Dudnik, Julia;
    • Urban, Damien;
    • Kian, Waleed;
    • Cohen, Aharon Y.;
    • Moskovitz, Mor;
    • Zer, Alona;
    • Bar, Jair;
    • Rabinovich, Natalie Maimon;
    • Grynberg, Shirly;
    • Oedegaard, Cecilie;
    • Agbarya, Abed;
    • Peled, Nir;
    • Shochat, Tzippy;
    • Dudnik, Elizabeth
    Publication type:
    Article
    42
    43